Synthesis and antimicrobial evaluation of sulfanilamide- and carbohydrate-derived 1,4-disubstitued-1,2,3-triazoles via click chemistry
dc.contributor.author | Ay K. | |
dc.contributor.author | Ispartaloğlu B. | |
dc.contributor.author | Halay E. | |
dc.contributor.author | Ay E. | |
dc.contributor.author | Yaşa İ. | |
dc.contributor.author | Karayıldırım T. | |
dc.date.accessioned | 2024-07-22T08:10:41Z | |
dc.date.available | 2024-07-22T08:10:41Z | |
dc.date.issued | 2017 | |
dc.description.abstract | 4-Sulfanilamido substitued-1,2,3-triazoles conjugated with monosaccharides (8–17) including d-glucose, d-galactose, d-mannose, and d-fructose were synthesized in good yields from azidosugars with propargyl sulfanilamides using copper catalyst 1,3-dipolar cycloaddition reaction (CuAAC). The structures of new compounds were elucidated by liquid chromatography-mass spectrometry, infrared, one-dimensional- and two-dimensional-nuclear magnetic resonance techniques. All of the new compounds were tested in vitro against Staphylococcus aureus, Bacillus subtilis, Escherichia coli, Salmonella typhimurium, Klebsiella pneumoniae, Enterococcus faecalis, Pseudomonas aeruginosa, and Candida albicans for their antibacterial and antifungal activities. Experimental results showed antimicrobial activity with minimum inhibitory concentrations values a ranging from 0.078 to 5.0 mg/mL against test microorganisms. © 2017, Springer Science+Business Media New York. | |
dc.identifier.DOI-ID | 10.1007/s00044-017-1864-3 | |
dc.identifier.issn | 10542523 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/15344 | |
dc.language.iso | English | |
dc.publisher | Birkhauser Boston | |
dc.subject | 1,2,3 triazole derivative | |
dc.subject | 4 ({[4' acetamidobenzenesulfonyl]amino}methyl) 1 (2",3",4",6" di o acetyl beta dextro mannofuranosyl) 1h 1,2,3 triazole | |
dc.subject | 4 ({[4' acetamidobenzenesulfonyl]amino}methyl) 1 (2",3",4",6" di o isopropylidene beta dextro fructopyranosyl) 1h 1,2,3 triazole | |
dc.subject | 4 ({[4' acetamidobenzenesulfonyl]amino}methyl) 1 (2",3",4",6" tetra o acetyl beta dextro galactopyranosyl) 1h 1,2,3 triazole | |
dc.subject | 4 ({[4' acetamidobenzenesulfonyl]amino}methyl) 1 (2",3",4",6" tetra o acetyl beta dextro glucopyranosyl) 1h 1,2,3 triazole | |
dc.subject | 4 ({[4' acetamidobenzenesulfonyl]amino}methyl) 1 (6'' deoxy 1",2" | |
dc.subject | 3",4" di o isopropylidene alpha dextro galactopyranose 6" yl) 1h 1,2,3 triazole | |
dc.subject | antibiotic agent | |
dc.subject | antifungal agent | |
dc.subject | carbohydrate derivative | |
dc.subject | sulfanilamide derivative | |
dc.subject | unclassified drug | |
dc.subject | antibacterial activity | |
dc.subject | antifungal activity | |
dc.subject | Article | |
dc.subject | Bacillus subtilis | |
dc.subject | Candida albicans | |
dc.subject | controlled study | |
dc.subject | drug screening | |
dc.subject | drug synthesis | |
dc.subject | Enterococcus faecalis | |
dc.subject | Escherichia coli | |
dc.subject | in vitro study | |
dc.subject | Klebsiella pneumoniae | |
dc.subject | liquid chromatography-mass spectrometry | |
dc.subject | melting point | |
dc.subject | minimum inhibitory concentration | |
dc.subject | nonhuman | |
dc.subject | nuclear Overhauser effect | |
dc.subject | proton nuclear magnetic resonance | |
dc.subject | Pseudomonas aeruginosa | |
dc.subject | Salmonella enterica serovar Typhimurium | |
dc.subject | Staphylococcus aureus | |
dc.title | Synthesis and antimicrobial evaluation of sulfanilamide- and carbohydrate-derived 1,4-disubstitued-1,2,3-triazoles via click chemistry | |
dc.type | Article |